Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI could spot hidden heart risks in menopausal women

NCT ID NCT07695376

Recruiting now Knowledge-focused Sponsor: Biogipuzkoa Health Research Institute Source: ClinicalTrials.gov ↗

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This study aims to develop an artificial intelligence tool that can better predict a woman's risk of heart disease during the menopausal transition. Researchers will collect health data from 3,000 women aged 40 to 60 across Europe and Colombia, including blood tests, blood pressure readings, and electronic health records. The goal is to create a personalized risk score that could lead to earlier prevention strategies, though no treatments are being tested in this observational study.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a personalized AI tool that helps doctors identify women at high risk for heart disease during menopause, enabling earlier prevention.
What could go wrong
This is an observational study, so it does not test a treatment. The AI models may not be accurate enough for widespread use, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTIFICIAL INTELLIGENCE (AL) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARTIFICIAL INTELLIGENCE (AL) CARDIOVASCULAR (CV) RISK CARDIOVASCULAR DISEASE RISK FACTOR MENOPAUSE PERIMENOPAUSE WOMEN (BETWEEN 30 TO 60 YEARS OLD)

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Biogipuzkoa Health Research Institute

    RECRUITING

    San Sebastián, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Ethniko Kai Kapodistriako Panepistimio Athinon

    RECRUITING

    Athens, Greece

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Fundacion Para La Gestion de La Investigacion En Salud de Sevilla

    RECRUITING

    Seville, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Keralty SAS

    NOT_YET_RECRUITING

    Bogotá, Colombia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Magdalena - Klinika Za Kardiovaskularne Bolesti Medicinskog Fakultetasveucilista J.J. Strossmayera U Osijeku Ustanova

    NOT_YET_RECRUITING

    Krapinske Toplice, Croatia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Viesoji Istaiga Vilniaus Universiteto Ligonine Santaros Klinikos

    NOT_YET_RECRUITING

    Vilnius, Lithuania

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.